American Realty Capital Properties Inc. (NASDAQ:ARCP) said Wednesday it plans to sell substantially all of its multi-tenant shopping center portfolio to a Blackstone Group fund for $1.98 billion in cash. American Realty Capital Properties Inc. (NASDAQ:ARCP) stock opened today at $12.66 and is currently trading at $12.55. The stock showed a negative weekly performance of -3.66%.
The strongest emerging players in the shipping and allied sectors, NewLead Holdings Ltd (NASDAQ:NEWL) has excelled in its field globally. It is continuously moving towards achieving operational growth to muster more consumer base and market share. On the financial front, NEWL has recently announced a reverse split to be effectual soon for smooth functioning of its business. Further, NEWL is also geared up to present its annual report providing deeper insight into its business outlook, potential and future strategies. Thus, NEWL is moving consistently towards attaining its growth targets of the FY14. NewLead Holdings Ltd (NASDAQ:NEWL) stock opened at $4.68, in current trading session and currently is at $4.29, by gaining 29.60%. The 52 week range of $0.38 – $8,235.02. Company’s market capitalization is 13.55 million.
FireEye, Inc. (NASDAQ:FEYE), the leader in stopping today’s advanced cyber-attacks, released the report “Cybersecurity’s Maginot Line: A Real-world Assessment of the Defense-in-Depth Model.” FireEye Inc. (NASDAQ:FEYE) stock is currently trading at $30.85. The EPS of the stock is -4.56. Company’s market capitalization is 4.48 billion.
Investment analysts at Topeka Capital Markets decreased their target price on shares of ARM Holdings plc (NASDAQ:ARMH) from $50.00 to $45.00 in a note issued to investors on Wednesday. The firm currently has a “buy” rating on the stock. Topeka Capital Markets’ price target would suggest a potential upside of 5.07% from the stock’s previous close. ARM Holdings plc (ADR) (NASDAQ:ARMH) stock opened the session at $43.47, and now is at $43.57. The 52 week range of the ARM Holdings plc (ADR) (NASDAQ:ARMH) stock remained $34.75 – $55.26 and the day range was $43.45 – $43.85.
Durham biopharmaceutical company Chimerix Inc. (NASDAQ:CMRX) priced its public offering at $14.22 per share. At those offering terms, Chimerix expects to raise about $104 million. It will use $60 million of that at least partly to fund a clinical trial it began after public pressure to provide its lead drug under development, brincidofovir, to Josh Hardy, a 7-year-old cancer survivor who suffered from an adenovirus infection. Chimerix Inc. (NASDAQ:CMRX) stock opened today at $14.64 and is currently trading at $15.37. The stock showed a negative weekly performance of -15.71%.